Troglitazone Action Is Independent of Adipose Tissue

作者: C F Burant , S Sreenan , K Hirano , T A Tai , J Lohmiller

DOI: 10.1172/JCI119839

关键词:

摘要: We have investigated the antidiabetic action of troglitazone in aP2/DTA mice, whose white and brown fat was virtually eliminated by fat-specific expression diphtheria toxin A chain. mice had markedly suppressed serum leptin levels were hyperphagic, but did not gain excess weight. fed a control diet hyperlipidemic, hyperglycemic, hyperinsulinemia indicative insulin-resistant diabetes. Treatment with alleviated hyperglycemia, normalized tolerance to intraperitoneally injected glucose, significantly decreased elevated insulin levels. Troglitazone also cholesterol, triglycerides, free fatty acids both wild-type mice. The decrease triglycerides due marked reduction VLDL- LDL-associated triglyceride. In skeletal muscle, triglyceride compared controls, glycogen increased. treatment hepatic increased muscle content without affecting peroxisomal proliferator-activated receptor gamma mRNA liver slightly changed treatment. results demonstrate that resistance diabetes can occur animals significant adipose deposits. Furthermore, alter glucose lipid metabolism independent its effects on tissue.

参考文章(36)
Y Zhu, K Alvares, Q Huang, M S Rao, J K Reddy, Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. Journal of Biological Chemistry. ,vol. 268, pp. 26817- 26820 ,(1993) , 10.1016/S0021-9258(19)74184-2
S. Sreenan, J. Sturis, W. Pugh, C. F. Burant, K. S. Polonsky, Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone American Journal of Physiology-endocrinology and Metabolism. ,vol. 271, ,(1996) , 10.1152/AJPENDO.1996.271.4.E742
P De Vos, A M Lefebvre, S G Miller, M Guerre-Millo, K Wong, R Saladin, L G Hamann, B Staels, M R Briggs, J Auwerx, Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. Journal of Clinical Investigation. ,vol. 98, pp. 1004- 1009 ,(1996) , 10.1172/JCI118860
I. Inoue, K. Takahashi, S. Katayama, Y. Harada, K. Negishi, A. Itabashi, J. Ishii, Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, Liver Glycogen synthase activity, and β-oxidation in fructose-fed rats Metabolism-clinical and Experimental. ,vol. 44, pp. 1626- 1630 ,(1995) , 10.1016/0026-0495(95)90085-3
S.R. Ross, R.A. Graves, B.M. Spiegelman, Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity Trends in Genetics. ,vol. 9, pp. 343- ,(1993) , 10.1016/0168-9525(93)90035-G
M. N. Ghazzi, J. E. Perez, T. K. Antonucci, J. H. Driscoll, S. M. Huang, B. W. Faja, R. W. Whitcomb, , Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes. ,vol. 46, pp. 433- 439 ,(1997) , 10.2337/DIAB.46.3.433
S Levak-Frank, H Radner, A Walsh, R Stollberger, G Knipping, G Hoefler, W Sattler, P H Weinstock, J L Breslow, R Zechner, Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. Journal of Clinical Investigation. ,vol. 96, pp. 976- 986 ,(1995) , 10.1172/JCI118145
Bruce M Spiegelman, Jeffrey S Flier, Adipogenesis and obesity: rounding out the big picture. Cell. ,vol. 87, pp. 377- 389 ,(1996) , 10.1016/S0092-8674(00)81359-8
Yiying Zhang, Ricardo Proenca, Margherita Maffei, Marisa Barone, Lori Leopold, Jeffrey M. Friedman, Positional cloning of the mouse obese gene and its human homologue Nature. ,vol. 372, pp. 425- 432 ,(1994) , 10.1038/372425A0
G. S. Hotamisligil, B. M. Spiegelman, Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. ,vol. 43, pp. 1271- 1278 ,(1994) , 10.2337/DIAB.43.11.1271